Stelis Biopharma
Stelis Biopharma is a biopharmaceutical company that delivers affordable treatments to patients in both emerging and developed markets.
Business Model:
Revenue: $0
Employees: 201-500
Industries / Tags:
Detailed Stelis Biopharma Information
Geographic Data
Address:
City: Bangalore
State: Karnataka
Zip:
Country: India
Financial Info
Stage:
series c
Raised Last:
$125M
Raised Total:$230M
Social
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Stelis Biopharma is a biopharmaceutical company that delivers affordable treatments to patients in both emerging and developed markets. It provides a one-stop-shop with comprehensive capabilities from Cell line and Process Development through to scale up, cGMP manufacturing, and fills/finish of proteins and peptides. Offer services at every stage of the development life cycle from Pre-Clinical and Clinical Development to Commercial Supply. At Stelis BioSource™, we assure customers of CDMO/CMO services, our deep commitment to Quality, Service, and Compliance. Stelis Biopharma Pvt. Ltd. (Stelis) was started in 2013 by Strides Pharma Science Limited (Strides) to drive a global affordable biopharma business. Via on-going investment, Strides remains a majority owner of Stelis alongside GMS Holdings and Tenshi Life Sciences. It continues to operate as an independent and autonomous subsidiary company.
Contact Phone:
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 11/2018 | Series B | $0 |
GMS Holdings Strides Pharma Science Tenshi Life Sciences GMS Holdings Strides Pharma Science Tenshi Life Sciences |
3/2021 | Series C | $0 |
GMS Holdings Mankekar Family Office RouteOne Think Investments TPG Growth GMS Holdings Mankekar Family Office RouteOne Think Investments TPG Growth |
3/2021 | Series B | $0 |
GMS Holdings Strides Pharma Science GMS Holdings Strides Pharma Science |
3/2021 | Series B | 2 | $70M |
GMS Holdings Strides Pharma Science GMS Holdings Strides Pharma Science |
3/2021 | Series C | 5 | $125M |
GMS Holdings Mankekar Family Office RouteOne Think Investments TPG Growth GMS Holdings Mankekar Family Office RouteOne Think Investments TPG Growth |
11/2018 | Series B | 3 | $35M |
GMS Holdings Strides Pharma Science Tenshi Life Sciences GMS Holdings Strides Pharma Science Tenshi Life Sciences |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
